Delayed targeted atelectasis in a case of bronchoscopic lung volume reduction with endobronchial valves.
Nikitha C ChandraIsabel Fernandez-BussyKatherine L WalshDavid Abia-TrujilloPublished in: BMJ case reports (2024)
A woman in her late 60s with severe chronic obstructive pulmonary disease (COPD) and emphysema underwent bronchoscopic lung volume reduction (BLVR) with endobronchial valves (EBV) to address hyperinflation. The initial EBV placement has led to partial lobar atelectasis of the left lower lobe and resulted in significant improvement in the patient's symptoms and lung function. However, valve migration occurred later due to pneumothorax unrelated to valves, leading to suboptimal clinical improvement. The patient achieved delayed full lobar atelectasis 21 months after EBV placement, which led to a significant clinical improvement. The patient decided to be delisted from the lung transplant list due to the improvement. This case highlights the importance of considering delayed atelectasis as a possible outcome of EBV placement and suggests the need for further exploration of the long-term implications and associations of this procedure.
Keyphrases
- lung function
- chronic obstructive pulmonary disease
- epstein barr virus
- ultrasound guided
- aortic valve
- case report
- diffuse large b cell lymphoma
- cystic fibrosis
- air pollution
- aortic valve replacement
- aortic stenosis
- coronary artery disease
- fine needle aspiration
- cancer therapy
- early onset
- transcatheter aortic valve replacement
- physical activity
- minimally invasive
- transcatheter aortic valve implantation
- idiopathic pulmonary fibrosis
- cord blood
- drug delivery
- ejection fraction